1995 - Member of the National Academy of Medicine (NAM)
His scientific interests lie mostly in Surgery, Sarcoma, Cancer, Survival rate and Soft tissue sarcoma. His Surgery study incorporates themes from Radiology, Internal medicine and Metastasis. His research integrates issues of Gastroenterology and Oncology in his study of Internal medicine.
The concepts of his Sarcoma study are interwoven with issues in Survival analysis, Radiation therapy and Soft tissue. He has researched Survival rate in several fields, including Carcinoma, Univariate analysis, Stage, Colorectal cancer and Adenocarcinoma. His Prospective cohort study research is multidisciplinary, relying on both Randomized controlled trial, Proportional hazards model and Clinical trial.
His primary areas of investigation include Surgery, Internal medicine, Cancer, Sarcoma and Soft tissue sarcoma. His Surgery study frequently intersects with other fields, such as Adenocarcinoma. Murray F. Brennan combines subjects such as Pancreatic cancer and Pancreas with his study of Adenocarcinoma.
His work deals with themes such as Gastroenterology, Endocrinology and Oncology, which intersect with Internal medicine. His study explores the link between Cancer and topics such as Surgical oncology that cross with problems in General surgery. His Sarcoma research incorporates themes from Proportional hazards model and Primary tumor, Metastasis.
Murray F. Brennan mostly deals with Surgery, Cancer, Internal medicine, Sarcoma and Pathology. His work in Surgery addresses issues such as Radiology, which are connected to fields such as Chemotherapy. His Cancer research is multidisciplinary, incorporating perspectives in Stage, Surgical oncology and Family medicine.
His biological study spans a wide range of topics, including Gastroenterology and Oncology. Murray F. Brennan studied Sarcoma and Soft tissue that intersect with Adult patients and Prognostic variable. His Survival rate research is multidisciplinary, incorporating elements of Prospective cohort study, Carcinoma and Adjuvant therapy.
The scientist’s investigation covers issues in Surgery, Internal medicine, Surgical oncology, Survival rate and Oncology. His work carried out in the field of Surgery brings together such families of science as Nomogram and Sarcoma. His Sarcoma research includes elements of Combined Modality Therapy, Proportional hazards model and Soft tissue.
In his study, which falls under the umbrella issue of Internal medicine, Lymph node is strongly linked to Gastroenterology. His Surgical oncology research integrates issues from Cancer, Breast cancer, Pancreatic cancer, Neuroendocrine tumors and Stage. The various areas that he examines in his Survival rate study include Prospective cohort study, Adjuvant therapy and Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer: Analysis of 1001 Consecutive Cases
Yuman Fong;Joseph Fortner;Ruth L. Sun;Murray F. Brennan.
Annals of Surgery (1999)
Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival.
Ronald P. Dematteo;Jonathan J. Lewis;Denis H. Y. Leung;Salvinder S. Mudan.
Annals of Surgery (2000)
Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial.
Ronald P. DeMatteo;Karla V. Ballman;Cristina R. Antonescu;Robert G. Maki.
The Lancet (2009)
Analysis of prognostic factors in 1,041 patients with localized soft tissue sarcomas of the extremities.
P. W. T. Pisters;Denis H. Y. Leung;J. M. Woodruff;W. Shi.
Journal of Clinical Oncology (1996)
The treatment of soft-tissue sarcomas of the extremities: prospective randomized evaluations of (1) limb-sparing surgery plus radiation therapy compared with amputation and (2) the role of adjuvant chemotherapy.
S A Rosenberg;J Tepper;E Glatstein;J Costa.
Annals of Surgery (1982)
Determinants of Long-Term Survival After Major Surgery and the Adverse Effect of Postoperative Complications
Shukri F. Khuri;Shukri F. Khuri;William G. Henderson;Ralph G. DePalma;Cecilia Mosca.
Annals of Surgery (2005)
Long-term results of a prospective randomized trial of adjuvant brachytherapy in soft tissue sarcoma.
P. W. T. Pisters;L. B. Harrison;Denis H. Y. Leung;J. M. Woodruff.
Journal of Clinical Oncology (1996)
Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure
James S. Tomlinson;William R. Jarnagin;Ronald P. DeMatteo;Yuman Fong.
Journal of Clinical Oncology (2007)
Prognostic indicators for survival after resection of pancreatic adenocarcinoma.
Richard J. Geer;Murray F. Brennan.
American Journal of Surgery (1993)
Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer
Nancy Kemeny;Ying Huang;Alfred M. Cohen;Weiji Shi.
The New England Journal of Medicine (1999)
Profile was last updated on December 6th, 2021.
Research.com Ranking is based on data retrieved from the Microsoft Academic Graph (MAG).
The ranking h-index is inferred from publications deemed to belong to the considered discipline.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: